Women's reproductive related disorders: a new proposal for the mental health field

被引:0
作者
Flores-Ramos, Monica [1 ]
机构
[1] Inst Nacl Perinatol Isidro Espinoza de los Reyes, Mexico City 01030, DF, Mexico
来源
GACETA MEDICA DE MEXICO | 2011年 / 147卷 / 01期
关键词
Mental disorder; Women; Premenstrual dysphoria; Postpartum depression; Perimenopausal depression; NOREPINEPHRINE REUPTAKE INHIBITOR; POSTPARTUM DEPRESSION; MENOPAUSAL TRANSITION; POSTNATAL DEPRESSION; REPLACEMENT THERAPY; RISK-FACTORS; LIFE-CYCLE; PREVALENCE; SYMPTOMS; ESTROGEN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, a research group has suggested the existence of women's disorders that may be grouped together as reproductive-related disorders, characterized by their timing (related to reproductive processes), shared vulnerability, and a common pathophysiology. Symptoms of reproductive-related disorders could be different among women, but are consistent within each individual woman and always present during reproductive-life periods including pregnancy, postpartum, and the premenstrual and perimenopausal periods. An association between hormonal changes and affective disorders is suggested as a physiopathology process of reproductive-related disorders, with an abnormal adaptation to hormonal changes in vulnerable women. In this paper we describe some characteristics of premenstrual dysphoria disorder, postpartum depression, and perimenopausal depression. A proposed pathophysiology of these disorders is described and pharmacologic options for treatment are also reviewed.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 61 条
[1]   A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: Effect on mood, cognition and quality of life [J].
Almeida, OP ;
Lautenschlager, NT ;
Vasikaran, S ;
Leedman, P ;
Gelavis, A ;
Flicker, L .
NEUROBIOLOGY OF AGING, 2006, 27 (01) :141-149
[2]  
Alvarado-Esquivel C, 2010, GAC MED MEX, V146, P1
[3]  
American Psychiatric Association, 1994, Manual Diagnostico y Estadistico de los Trastornos Mentales (DSM-IV), V4th
[4]  
[Anonymous], 2008, Harvard Women's Health Watch, V15, P1
[5]  
[Anonymous], CNS SPECTR
[6]  
[Anonymous], 2000, ACOG PRACTICE B, V12, P1, DOI [DOI 10.1016/S0029-7844(99)00580-3, 10.1016/S0029-7844(99)00580-3]
[7]   Desvenlafaxine succinate (DVS), a novel serotonin and norepinephrine reuptake inhibitor, improves mood and menopausal symptoms in women with hot flushes (HFS) associated with menopause. [J].
Archer, D. F. ;
DuPont, C. ;
Constantine, G. ;
Pickar, J. ;
Olivier, S. .
FERTILITY AND STERILITY, 2007, 88 :S246-S246
[8]   Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine [J].
Berlanga, Carlos ;
Flores-Ramos, Monica .
JOURNAL OF AFFECTIVE DISORDERS, 2006, 95 (1-3) :119-123
[9]   Women's mental health research: The emergence of a biomedical field [J].
Blehar, Mary C. .
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, 2006, 2 :135-160
[10]  
Borenstein JE, 2003, J REPROD MED, V48, P515